Holy Grail: Re-wiring the immune response to prevent asthma
18 Jun 2019
Dr Rhys Allan
Dr Rhys Allan is a scientist in the molecular immunology division of the Walter and Eliza Hall Institute of Medical Research. His laboratory focuses on targeting the epigenetic changes that are associated with allergic disease and infection.
Can you describe the aim of this project in 10 words? To discover new strategies to treat allergic asthma. What have you discovered so far in this area? Our recent research, in an experimental model, showed that the enzyme known as enhancer of zeste homolog 2 (Ezh2) is essential for T cells to drive allergic ...